3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Interventions
Oxaliplatin
149
Fluorouracil
136
Gemcitabine
117
Bevacizumab
115
Leucovorin
106
Specimen Handling
105
Capecitabine
95
pembrolizumab
89
Magnetic Resonance Spectroscopy
83
Cisplatin
79
Nivolumab
77
Irinotecan
71
durvalumab
63
Cetuximab
62
Paclitaxel
60
Biopsy
60
130-nm albumin-bound paclitaxel
60
atezolizumab
44
Radiotherapy
44
Taxes
36
Carboplatin
36
Albumin-Bound Paclitaxel
36
Folfox protocol
35
Drug Therapy
31
Cyclophosphamide
30
lenvatinib
29
dehydroftorafur
28
tislelizumab
27
sintilimab
27
Radiation
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chemoradiotherapy, Adjuvant
×
Gastrointestinal
×
90 days
×
Clear all
NCT05667298
2026-05-11
OPERARADIO
University of Manitoba
Phase 1
Active not recruiting
11 enrolled